Lead Product(s) : Lurbinectedin
Therapeutic Area : Oncology
Study Phase : Undisclosed
Sponsor : Stand Up To Cancer
Deal Size : Undisclosed
Deal Type : Collaboration
Details : The collaboration will provide SU2C-funded researchers access to two Jazz molecules and funds to support one or more research projects over three years. One of the projects would help explore clinical use of lurbinectedin in rare and hard to treat pediat...
Product Name : Zepzelca
Product Type : Cytotoxic Drug
Upfront Cash : Undisclosed
October 08, 2021
Lead Product(s) : Lurbinectedin
Therapeutic Area : Oncology
Highest Development Status : Undisclosed
Sponsor : Stand Up To Cancer
Deal Size : Undisclosed
Deal Type : Collaboration